121 related articles for article (PubMed ID: 20660990)
1. Hallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in senescence-accelerated mice.
Niimi K; Takahashi E; Itakura C
Exp Anim; 2010; 59(4):441-7. PubMed ID: 20660990
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
[TBL] [Abstract][Full Text] [Related]
3. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
Schindler EA; Harvey JA; Aloyo VJ
Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
[TBL] [Abstract][Full Text] [Related]
5. Combination of modified SHIRPA and pharmacological approach uncovers neuronal alteration in senescence-accelerated mouse prone 6 (SAMP6) strain.
Niimi K; Takahashi E
Neurosci Lett; 2009 Jul; 458(2):53-6. PubMed ID: 19393718
[TBL] [Abstract][Full Text] [Related]
6. Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
Garcia EE; Smith RL; Sanders-Bush E
Neuropharmacology; 2007 Jun; 52(8):1671-7. PubMed ID: 17493641
[TBL] [Abstract][Full Text] [Related]
7. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
[TBL] [Abstract][Full Text] [Related]
8. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.
Santini MA; Balu DT; Puhl MD; Hill-Smith TE; Berg AR; Lucki I; Mikkelsen JD; Coyle JT
Behav Brain Res; 2014 Feb; 259():242-6. PubMed ID: 24269270
[TBL] [Abstract][Full Text] [Related]
9. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
[TBL] [Abstract][Full Text] [Related]
10. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
11. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
12. G
Liu X; Zhu H; Gao H; Tian X; Tan B; Su R
Biochem Biophys Res Commun; 2022 Apr; 598():20-25. PubMed ID: 35149433
[TBL] [Abstract][Full Text] [Related]
13. Age-related difference in nociceptive behavior between SAMP6 and SAMR1 strains.
Niimi K; Takahashi E; Itakura C
Neurosci Lett; 2008 Oct; 444(1):60-3. PubMed ID: 18703115
[TBL] [Abstract][Full Text] [Related]
14. Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice.
Hazama K; Hayata-Takano A; Uetsuki K; Kasai A; Encho N; Shintani N; Nagayasu K; Hashimoto R; Reglodi D; Miyakawa T; Nakazawa T; Baba A; Hashimoto H
PLoS One; 2014; 9(2):e89153. PubMed ID: 24586556
[TBL] [Abstract][Full Text] [Related]
15. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
Schmid CL; Raehal KM; Bohn LM
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
Smith DA; Bailey JM; Williams D; Fantegrossi WE
J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256
[TBL] [Abstract][Full Text] [Related]
17. Diabetes inhibits the DOI-induced head-twitch response in mice.
Miyata S; Hirano S; Kamei J
Psychopharmacology (Berl); 2004 Dec; 177(1-2):224-9. PubMed ID: 15290007
[TBL] [Abstract][Full Text] [Related]
18. Age dependence of motor activity and sensitivity to dopamine receptor 1 agonist, SKF82958, of inbred AKR/J, BALB/c, C57BL/6J, SAMR1, and SAMP6 strains.
Niimi K; Takahashi E; Itakura C
Brain Res; 2009 Jan; 1250():175-82. PubMed ID: 19007759
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
[TBL] [Abstract][Full Text] [Related]
20. Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors.
Moya PR; Berg KA; Gutiérrez-Hernandez MA; Sáez-Briones P; Reyes-Parada M; Cassels BK; Clarke WP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1054-61. PubMed ID: 17337633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]